The Conversation (0)
- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Trending
Trending Articles
Trending Press Releases
Trending Companies
Trending Reports
Resource
Popular Lists
Investing Ideas
Outlook Reports
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
Investing Guides
Tech
Popular Lists
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
Investing Ideas
Outlook Reports
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
Investing Guides
Life Science
Popular Lists
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
Outlook Reports
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Investing Guides
Avalon GloboCare Announces Listing on NASDAQ Capital Market
Nov. 05, 2018 08:53AM PST
Biotech InvestingAvalon GloboCare (NASDAQ:AVCO) has been approved for listing its common stock on the NASDAQ Capital Market. As quoted in the press release: Trading on NASDAQ is expected to commence today, November 5, 2018 under the current trading symbol, AVCO. David Jin, M.D., Ph.D., President and CEO of Avalon GloboCare, stated, “In the past year alone, …
Avalon GloboCare (NASDAQ:AVCO) has been approved for listing its common stock on the NASDAQ Capital Market.
As quoted in the press release:
Trading on NASDAQ is expected to commence today, November 5, 2018 under the current trading symbol, AVCO.
David Jin, M.D., Ph.D., President and CEO of Avalon GloboCare, stated, “In the past year alone, we have made significant strides in developing and commercializing innovative and transformative cell-based technologies. Listing on NASDAQ provides us greater exposure within the investment community as we execute on key upcoming milestones, including expansion into new verticals and markets worldwide, partnerships with major universities and biotech companies, and acceleration of our growth within the cell therapy, liquid biopsy and regenerative medicine markets.”
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.